Myocarditis News and Research

RSS

In medicine (cardiology), myocarditis is inflammation of heart muscle (myocardium). It resembles a heart attack but coronary arteries are not blocked.

New analysis on the risk for myocarditis or pericarditis after mRNA COVID-19 vaccination

A comprehensive review and meta-analysis of published research confirm that young adults (40 years old and younger) have a slightly elevated risk for myocarditis or pericarditis after mRNA COVID-19 vaccination.

1 Nov 2022

A study of Moderna's COVID vaccine in children aged 6 months to 5 years

In a recent study published in the New England Journal of Medicine, researchers presented the findings of the ongoing KidCOVE trial in the United States (US).

23 Oct 2022

Study shows low risk of myocarditis/pericarditis after mRNA COVID-19 vaccination

Scientists determine the risk of myocarditis and pericarditis among young individuals who have received mRNA-based COVID-19 vaccines.

19 Oct 2022

Pathophysiological mechanisms of COVID-19-related endothelial dysfunction and potential therapies

Researchers discussed the pathophysiological mechanisms of endothelial dysfunction associated with severe coronavirus disease 2019 (COVID-19) and commented on the potential therapeutic strategies to treat endothelial damage and coagulopathy related to COVID-19.

19 Oct 2022

Reduced cardiac function identified in severe COVID-19 patients in new study

In a new study, researchers assessed the cardiac function in patients experiencing severe coronavirus disease 2019 (COVID-19).

17 Oct 2022

What is the impact of COVID-19 and organophosphates on cardiac health?

In a new study, researchers discussed the impacts of organophosphates (OP) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on cardiovascular (CVS) health.

17 Oct 2022

Researchers explore single-cell sequencing technologies to understand molecular mechanisms of autoimmune diseases

A new review discussed the applications of single-cell ribonucleic acid sequencing (scRNA-seq) in understanding autoimmune disorders.

17 Oct 2022

Myocarditis induced by COVID-19 infection is substantially greater than the risk posed by vaccines

The risk of developing myocarditis - or inflammation of the heart muscle - is seven times higher with a COVID-19 infection than with the COVID-19 vaccine, according to a recent study by Penn State College of Medicine scientists.

13 Oct 2022

Cardiovascular risk factors – not preexisting heart disease – are the main contributors to COVID-19 death

A national study suggests that risk factors for cardiovascular disease, such as age, smoking and diabetes – not preexisting heart disease – are the main contributors to death and poor outcomes for critically ill COVID-19 patients.

12 Oct 2022

Study explores cell signaling dysregulation and COVID-19 severity

Researchers assessed the impact of dysregulation in cell signaling events on coronavirus disease 2019 (COVID-19) severity.

12 Oct 2022

Are men or women impacted more by adverse reactions to prescription drug treatments?

Recently, researchers presented an overview of sex-based differences in adverse drug reactions (ADRs) based on epidemiology, technique, and underlying mechanism data.

11 Oct 2022

Myocarditis may be attributable to monkeypox infection

A new study published in Emerging Infectious Diseases found that myocardial infiltration could cause myocarditis during monkeypox virus infection.

5 Oct 2022

Clinical features and outcomes of fulminant myocarditis revealed by nationwide cohort study

Myocarditis is an inflammatory disease of the myocardium often caused by viral infections or autoimmune disorders. Fulminant myocarditis (FM) is a rare and severe presentation of myocarditis characterized by hemodynamically unstable conditions requiring inotropes and/or mechanical circulatory support.

30 Sep 2022

Long-term follow-up of young people with COVID-19 vaccine myocarditis

In a recent study, researchers surveyed a comprehensive range of outcomes in patients diagnosed with myocarditis after COVID-19 vaccination in the United States.

26 Sep 2022

Trial tests efficacy and safety of NVX-CoV2373 COVID-19 vaccine among adolescents

In a recent study posted to the medRxiv* preprint server, researchers in the United States described the safety, efficacy, and immunogenicity of the NVX-CoV2373 vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), tested in PREVENT-19 — a phase 3, randomized, placebo-controlled, observer-blinded trial among 12- to 17-year-old adolescents in the United States (U.S).

25 Sep 2022

How smallpox and monkeypox viruses affect the nervous system

A recent study provides an overview of existing literature on the complications of infection with both smallpox and monkeypox virus.

25 Sep 2022

BU investigator wins highly competitive awards to study the role of proteases in regulation of cellular defenses

Mohsan Saeed, PhD, assistant professor of biochemistry at Boston University School of Medicine (BUSM), has received a five-year, $2 million R35 grant from the National Institute of General Medical Sciences, as well as a five-year, $2.5 million R01 grant from the National Institute of Allergy and Infectious Diseases.

20 Sep 2022

Study explores the impact of genetic risk variants on overall disease burden and healthy life years

In a new study, researchers explored the genetic risk factors associated with various diseases to understand their impact on healthy life years.

14 Sep 2022

Can preclinical COVID-19 models help unlock mystery of long-COVID?

In a recently published article in the journal PLOS PATHOGENS, scientists have summarized acute and prolonged clinical manifestations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The review also provides an overview of the potency and utility of preclinical animal models to understand the mechanistic details of acute and long coronavirus disease 2019 (COVID-19).

8 Sep 2022

Researchers review the epidemiology, clinical character, treatment, and prevention of human monkeypox

Researchers reviewed the epidemiology, clinical character, treatment, and prevention of human monkeypox.

8 Sep 2022

Myocarditis News and Research

Further Reading

New analysis on the risk for myocarditis or pericarditis after mRNA COVID-19 vaccination

A study of Moderna's COVID vaccine in children aged 6 months to 5 years

Study shows low risk of myocarditis/pericarditis after mRNA COVID-19 vaccination

Pathophysiological mechanisms of COVID-19-related endothelial dysfunction and potential therapies

Reduced cardiac function identified in severe COVID-19 patients in new study

What is the impact of COVID-19 and organophosphates on cardiac health?

Researchers explore single-cell sequencing technologies to understand molecular mechanisms of autoimmune diseases

Myocarditis induced by COVID-19 infection is substantially greater than the risk posed by vaccines

Cardiovascular risk factors – not preexisting heart disease – are the main contributors to COVID-19 death

Study explores cell signaling dysregulation and COVID-19 severity

Are men or women impacted more by adverse reactions to prescription drug treatments?

Myocarditis may be attributable to monkeypox infection

Clinical features and outcomes of fulminant myocarditis revealed by nationwide cohort study

Long-term follow-up of young people with COVID-19 vaccine myocarditis

Trial tests efficacy and safety of NVX-CoV2373 COVID-19 vaccine among adolescents

How smallpox and monkeypox viruses affect the nervous system

BU investigator wins highly competitive awards to study the role of proteases in regulation of cellular defenses

Study explores the impact of genetic risk variants on overall disease burden and healthy life years

Can preclinical COVID-19 models help unlock mystery of long-COVID?

Researchers review the epidemiology, clinical character, treatment, and prevention of human monkeypox

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News